Miguel Sieler

President chez Neovacs, Inc.

Profil

Miguel Sieler is the founder of Abivax SA, which was founded in 2003.
He held the title of Director at Abivax SA from 2003 to 2015.
Mr. Sieler is currently the President & Director at Neovacs, Inc. and a Venture Partner at Truffle Capital SAS.
Mr. Sieler previously held the position of Chief Executive Officer & Director at Neovacs SA from 2013 to 2019.
He also held various leadership positions at Bayer Pharma France SA, Haarmann & Reimer Corp, Borchers SAS, Wittycell SAS, Bayer Sante Familiale SAS, Bayer SAS, Bayer Sante, ARLANXEO Elastomères France SAS, Demeta SAS, Natchem SAS, Ethypharm SAS, Nexity SA, Fondation de la Maison de la Chimie, Bayer Environmental Science SAS, Bayer Immobilier, Bayer HealthCare Ltd., Bayer CropScience SA, Plasmaprime SAS, and Lanxess SAS.
Mr. Sieler's education includes a graduate degree from Eberhard Karls Universität Tübingen and an undergraduate degree from Sciences Po.

Postes actifs de Miguel Sieler

Sociétés	Poste	Début
Truffle Capital SAS	Analyste en capital-investissement	17/12/2009
Neovacs, Inc.	President	-

Anciens postes connus de Miguel Sieler

Sociétés	Poste	Fin
NEOVACS	Directeur Général	30/09/2019
NEXITY	Directeur/Membre du Conseil	12/12/2016
ABIVAX	Fondateur	06/09/2015
Wittycell SAS	Président	01/07/2014
Haarmann & Reimer Corp	Président	-

Formation de Miguel Sieler

Eberhard Karls Universität Tübingen	Graduate Degree
Sciences Po	Undergraduate Degree